Last week to apply! Don't miss your chance to compete for $100K in the Eli Lilly and Company Grand Challenge. Apply by 7/12! https://lnkd.in/gaTtbBkU
Nucleate
Biotechnology Research
Nucleate empowers tomorrow's biotech leaders by educating today's academic trainees
About us
Nucleate is a nonprofit organization dedicated to empowering the next generation of biotech leaders. We believe that the grand challenges of our time will be solved by the academics who transform experiment into enterprise. Nucleate removes barriers so they can concentrate on building transformational technologies.
- Website
-
http://www.nucleate.xyz
External link for Nucleate
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Boston
- Type
- Nonprofit
- Founded
- 2019
Locations
-
Primary
Boston, US
-
New York City, US
-
Bay Area, US
-
San Diego, US
Employees at Nucleate
-
Lital Gilad-Shaoulian
Founder & CEO
-
Iris Stone, PhD
Computational Neuroscientist | Research Fellow at the Allen Institute | Biotech
-
Guy Rosenthal
Corporate Development, Laekna Therapeutics | Investor | Advisor | Chairman, The French Horn Fund | UCLA Anderson MBA
-
Ijah M. Crump, MD
Medical-clinical development professional driving pharma, biotech & med device industry research & innovation.
Updates
-
We are thrilled to announce that MilliporeSigma has renewed its sponsorship of Nucleate with a three-year commitment! This partnership significantly bolsters support for early-stage biotech companies emerging from Nucleate’s Activator program. Over the past five years, our Activator program has empowered 411 teams, helping them raise over $387 million and create more than 233 jobs. MilliporeSigma's renewed support underscores their dedication to nurturing the next generation of biotech innovators. MilliporeSigma’s experts will offer mentorship and valuable insights, enhancing our ventures' potential for innovation and growth. This collaboration is crucial for developing early-stage biotech talent and transforming groundbreaking ideas into impactful solutions. For more information about this partnership and opportunities for early-stage biotech companies, visit https://lnkd.in/geABJh-X.
-
-
Nucleate reposted this
TD National Scholar '22 | McMaster Integrated Chemical & Biomedical Engineering and Health Sciences '27 | Biochemistry and Infectious Disease Minors | Hoare Lab RA | Shad '21
I'm very eager to share with you all that near the end of August, I'll be attending the Nucleate Alumni Summit 2024, nestled in the heart of the California Redwoods at 1140 Multiversity in Scotts Valley, California! The annual Nucleate Alumni Summit is a once-a-year highlight of biotech, bringing together the best and brightest for a series of panel discussions (tree talks) that highlight various angles of bio-innovation including women in biotech, the future of AI, as well as fireside chats featuring esteemed biotech leaders and industry professionals united from chapters worldwide. In addition, students passionate about biotech and networking will gain valuable insights and mentorship that will empower their path to becoming the Key Opinion Leaders of tomorrow, and unlock a world of possibilities to position themselves for success in the life sciences and dynamic biotech field. I'd also like to thank Nucleate for supporting my and other students' attendance through their educational grant fund, eliminating cost barriers to attending! I can't wait to celebrate, learn, engage, and exchange ideas to grow and collaboratively shape the future of bio-innovation!
-
-
Only 11 days left to apply for the Eli Lilly and Company Grand Challenge! This is a unique opportunity to secure $100,000 in non-dilutive funding for your innovative project in genetics, drug delivery, or neuroscience. Apply now and don’t miss out on this incredible opportunity to network with Lilly executives and scientists. https://lnkd.in/gaTtbBkU
Nucleate Announces 3 Year Sponsorship with Eli Lilly and Company To Support Early-Stage Companies…
nucleatehq.medium.com
-
We are proud to have Mediso Medical Imaging Systems as a Gold sponsor for our Summit. Mediso is a leader in the field of Clinical and Pre-Clinical Medical Imaging equipment, with over +300 systems installed world-wide, partnering with the most influential research institutes that use SPECT-CT-Pet & MRI imaging to move science forward. With over 30+ years of experience in molecular imaging, Mediso has developed a reputation for innovation and high-quality imaging solutions. Their imaging solutions help healthcare professionals make new discoveries that impact the health of people worldwide. We invite you to visit Mediso's expo booth to learn more about their advanced imaging solutions and explore how they can support your healthcare and research needs. Get your earlybird ticket by July 15! summit.nucleate.org There's also still time to partner with us for our upcoming summit! We have launched the Nucleate Alumni Partnering Portal, designed to leverage our extensive networks to provide you with wisdom, support, and funding. Whether you’re seeking expertise from our network of mentors, financial backing from our capital partners, or operational support, we’re here to help you succeed. Fill out this short form to get started! https://lnkd.in/gg-qeFgP
-
-
Are you a Nucleate alum looking to elevate your biotech venture? 📈 The Nucleate Alumni Partnering Portal connects you with a vast network of experts, mentors, and sponsors ready to support your journey. Discover how you can gain invaluable insights and grow your startup with our dedicated support system. Whether you're launching a startup, seeking funding, looking for mentorship, or exploring job opportunities, we want to ensure you get the support you need. Get connected now by filling out this form! https://lnkd.in/gajJmt9K
-
-
Nucleate reposted this
We are thrilled to announce a gold-tier partnership between Nucleate Boston and Banc of California. Banc of California will be the exclusive banking sponsor of the Boston chapter of Nucleate for our 2024 Activator Innovators. Standing at the forefront of bespoke banking and treasury management, Banc of California provides services to small-, middle-market, and venture-backed businesses. With a deep understanding of the unique challenges and opportunities within the VC and PE landscapes, they are uniquely poised to support Nucleate's Activator teams. Their Venture Banking Group offers an extensive array of services including venture debt, fund finance, and comprehensive treasury management solutions, catering to key groups such as VC-backed multi-stage tech companies, VC and PE fund finance, emerging life science companies, and more. As the exclusive banking sponsor for 2023-2024, Banc of California's expertise and tailored financial services will serve our talented Activator innovators, further bolstering Boston's vibrant biotech ecosystem. We express our deepest gratitude to Banc of California for believing in our vision and for their invaluable support. Together, we look forward to paving the way for the next wave of innovations and democratizing biotechnology.
-
-
Nucleate reposted this
We’re excited to share the incredible success of Nucleate Germany's inaugural #Activator Season 2023-24! This #milestone represents 1.5 years of dedicated team effort, innovation, and community building within Germany’s biotech ecosystem. Our first Activator Demo Day in Berlin was a resounding success, reflecting the vibrant and diverse biotech community we have fostered. We extend our heartfelt thanks to all who attended and made it unforgettable – we hope you enjoyed it as much as we did! The evening was filled with remarkable moments, beginning with presentations from this years pioneering startups: Activa.TE, EscapeAGENT, Fluvion, Jellyfish Bio, MIMBIOSIS, Reactosome, RevoBITs, and Silica Corpora. This cohort‘s 8 teams are spearheading groundbreaking advancements in biotechnology, each offering unique solutions and transformative technologies across the biomedical and eco landscape We are excited to announce this year‘s winning teams: 🥇Germany #Activator main prize: RevoBITs 🏆MilliporeSigma Regional High Impact Culture Award: Reactosome 🏆Genentech Regional Diversity, Equity, and Inclusion Prize: EscapeAGENT 🏆Alnylam Pharmaceuticals Regional Scientific Excellence Award: Fluvion 🏆BioLabs Golden Ticket: Reactosome Thank you to our speakers whose insights made this event so remarkable: Ulrike Rauh (Sack) from PROSION Therapeutics and Trueline Therapeutics, Prateek M., CEO of BIOWEG , Jan-Philipp Kruse from Bayer Co.Lab, Dr. Anela Vukoja from Apollo Health Ventures, Univ.-Prof. Dr. Ing. Georg Duda from the Julius Wolff Institute at Charité - Universitätsmedizin Berlin, and Dorothée Marie-Louise Doepfer from BIH Digital Health Accelerator. We extend our deepest gratitude to our sponsors, and especially also to our dedicated mentors and experts who have supported the Activator program throughout the year. Special thanks to Dr. Philipp Marchand, Dr. Andreas Heiseke, Christian Schloerb from VOSSIUS, Carolin Clement from Berlin Partner für Wirtschaft und Technologie GmbH, and Ann-Kristin Mueller and Stefanie Schimmel from BioLabs. As we look to the future, we are excited about the potential we see in the German biotech startup landscape, upcoming Nucleate Germany events and our next Activator season as we continue to explore the forefront of biotech advancements. Join us in our journey to foster innovation, collaboration, and progress in the biotech sector and stay up to date via our newsletter!
-
-
-
-
-
+1
-
-
Nucleate reposted this
Fantastic way to interact with the global biotech community, definitely grab a spot - students can apply for free tickets!
The Summit is approaching fast! Don’t forget to grab your ticket at summit.nucleate.org. Early bird pricing ends July 15.
-
-
Huge congratulations to Cheri Ackerman, Jared Kehe, and the whole Concerto Biosciences team. Having participated in our inaugural 2019 Activator Program, we're immensely proud to see Concerto Biosciences making such impactful progress, and of course to have played a small role in your ongoing and evolving story! On behalf of Nucleate, we wish you all the best!
Drumroll please! Concerto Biosciences has officially secured an open Investigational New Drug (IND) application for Ensemble No.2 (ENS-002) First-In-Human clinical trials. In the biotech world, this is a pivotal moment, not only showcasing our technical rigor, but also representing a huge step toward improving patient lives with microbial treatments. Next stop: the clinic! https://lnkd.in/ek3BTYSk
Concerto Biosciences Receives FDA Investigational New Drug Clearance for Live Biotherapeutic Product to Treat Atopic Dermatitis - Concerto Biosciences
concertobio.com